• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lidocaine kinetics predicted by indocyanine green clearance.

作者信息

Zito R A, Reid P R

出版信息

N Engl J Med. 1978 May 25;298(21):1160-3. doi: 10.1056/NEJM197805252982102.

DOI:10.1056/NEJM197805252982102
PMID:651945
Abstract

To evaluate the importance of hepatic blood flow in lidocaine kinetics, we compared indocyanine green clearance, an estimate of hepatic plasma flow, to lidocaine clearance in 26 patients, half with and half without congestive heart failure, who received a lidocaine infusion for 24 hours as clinically indicated. The results demonstrated that patients with congestive heart failure had significantly higher steady-state lidocaine levels (6.8 +/- 3.6(S.D.) vs. 2.9 +/- 0.9 microgram per milliliter, P less than 0.005) and reduced lidocaine clearance (3.8 +/- 1.4 vs. 10.9 +/- 3.1 ml per minute per kilogram, P less than 0.005) than patients without heart failure. Potentially subtherapeutic or toxic lidocaine levels were found in 10 patients. The regression line (y = 0.3 + 1.07 x) relating clearance of lidocaine to that of indocyanine green was linear (r = 0.95, P less than 0.001). Since indocyanine green clearance can be determined rapidly and noninvasively, it offers the potential of predicting lidocaine dosage requirements with avoidance of toxicity or suboptimum therapy.

摘要

相似文献

1
Lidocaine kinetics predicted by indocyanine green clearance.
N Engl J Med. 1978 May 25;298(21):1160-3. doi: 10.1056/NEJM197805252982102.
2
Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.利多卡因动力学:早期利多卡因动力学与吲哚菁绿清除率之间的关系。
J Clin Pharmacol. 1981 Feb-Mar;21(2):100-5. doi: 10.1002/j.1552-4604.1981.tb01757.x.
3
Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.心律失常患者持续输注利多卡因。血浆浓度的不可预测性。
Arch Intern Med. 1981 Jan;141(1):43-5.
4
Lignocaine and indocyanine green kinetics in patients following myocardial infarction.心肌梗死后患者的利多卡因和吲哚菁绿动力学
Br J Clin Pharmacol. 1980 Oct;10(4):353-61. doi: 10.1111/j.1365-2125.1980.tb01771.x.
5
Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.H2受体拮抗剂对灌注大鼠肝脏中吲哚菁绿和利多卡因稳态摄取的影响。
J Lab Clin Med. 1986 Feb;107(2):112-7.
6
Simultaneous measurement of effective hepatic blood flow and systemic circulation.有效肝血流量与体循环的同步测量。
Hepatogastroenterology. 2000 Nov-Dec;47(36):1669-74.
7
The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.用吲哚菁绿评估肝血流量:连续输注法与单次注射法的比较
Am J Gastroenterol. 1982 Apr;77(4):233-7.
8
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.静脉推注和持续输注后完整猪体内吲哚菁绿的血浆清除:分光光度法和高压液相色谱法用于浓度分析的比较
Hepatology. 1993 Dec;18(6):1504-15.
9
Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.肝硬化患者肝脏摄取吲哚菁绿的药代动力学研究。
Am J Gastroenterol. 1985 Oct;80(10):801-6.
10
Therapy with antiarrhythmic drugs.抗心律失常药物治疗。
N Engl J Med. 1978 May 25;298(21):1193-4. doi: 10.1056/NEJM197805252982109.

引用本文的文献

1
Population Pharmacokinetics of Intravenous Lidocaine in Adults: A Systematic Review.成人静脉利多卡因的群体药代动力学:系统评价。
Clin Pharmacokinet. 2024 May;63(5):623-643. doi: 10.1007/s40262-024-01373-4. Epub 2024 May 4.
2
Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients.他克莫司在中国重症肌无力患者中的群体药代动力学分析。
Acta Pharmacol Sin. 2017 Aug;38(8):1195-1204. doi: 10.1038/aps.2016.174. Epub 2017 May 29.
3
Impact of obesity on drug metabolism and elimination in adults and children.
肥胖对成人和儿童药物代谢和消除的影响。
Clin Pharmacokinet. 2012 May 1;51(5):277-304. doi: 10.2165/11599410-000000000-00000.
4
Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.硝苯地平与重组组织型纤溶酶原激活剂在健康受试者中的相互作用研究。
Br J Clin Pharmacol. 1993 Aug;36(2):99-104. doi: 10.1111/j.1365-2125.1993.tb04203.x.
5
Assessment of liver metabolic function. Clinical implications.肝脏代谢功能评估。临床意义。
Clin Pharmacokinet. 1994 Sep;27(3):216-48. doi: 10.2165/00003088-199427030-00005.
6
Pharmacokinetic based adjustment of lidocaine antiarrhythmic schedule.
Eur J Drug Metab Pharmacokinet. 1994 Jan-Mar;19(1):33-6. doi: 10.1007/BF03188820.
7
Effect of dehydration and hyperosmolal hydration on lignocaine and metabolites disposition in conscious rabbits.脱水和高渗性水化对清醒家兔利多卡因及其代谢产物处置的影响。
Br J Pharmacol. 1994 Sep;113(1):317-23. doi: 10.1111/j.1476-5381.1994.tb16211.x.
8
Drug interactions with thrombolytic agents. Current perspectives.与溶栓药物的药物相互作用。当前观点
Clin Pharmacokinet. 1995 Apr;28(4):315-26. doi: 10.2165/00003088-199528040-00004.
9
Lignocaine and indocyanine green kinetics in patients following myocardial infarction.心肌梗死后患者的利多卡因和吲哚菁绿动力学
Br J Clin Pharmacol. 1980 Oct;10(4):353-61. doi: 10.1111/j.1365-2125.1980.tb01771.x.
10
A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.一种独立于药代动力学模型的方法,用于估算在血浆中达到所需稳态谷浓度所需的药物剂量。
J Pharmacokinet Biopharm. 1980 Feb;8(1):105-10. doi: 10.1007/BF01059452.